Dr Wei Zhao
Research Fellow
Department of Infectious Diseases
16 Scholarly works
3 Projects
HIGHLIGHTS
2025
Research grants (other domestic)
Developing CRISPR Cas13 Antiviral Therapeutics for Respiratory Pathogens of Pandemic Potential
2025
Journal article
Hepatitis B surface antigen is upregulated by HIV Tat in an HIV–hepatitis B virus co-infection model system
DOI: 10.1128/spectrum.00809-252025
Journal article
Opportunities and challenges for hepatitis B cure in people living with HIV and hepatitis B virus
DOI: 10.1002/jia2.700152025
Journal article
Efficient mRNA delivery to resting T cells to reverse HIV latency
DOI: 10.1038/s41467-025-60001-22024
Research contracts (non-grants)
In Vivo Analysis of Lung Targetting LNP
2024
Journal article
Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy
DOI: 10.1016/j.ebiom.2024.1050542022
Research grants (ARC, NHMRC, MRFF)
mRNA-based Antiviral Therapeutics for SARS-CoV-2 Using Cas13
RECENT SCHOLARLY WORKS
2023
Journal article
HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy
DOI: 10.1016/j.ebiom.2022.1043912022
Journal article
Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals
DOI: 10.1128/jvi.00588-222022
Conference Proceedings
De novo design of CRISPR-Cas13b enables efficient silencing of SARS-CoV-2 variants and tumour pathogenic RNAs with near single-base precision
DOI: 10.1016/j.pathol.2021.12.0572021
Journal article
BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection
DOI: 10.1016/j.cell.2021.03.0262020
Journal article
Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B coinfection
DOI: 10.1371/JOURNAL.PPAT.10087442019
Conference Proceedings
HBV-related inflammation is linked to the level of genetically intact HIV proviruses
DOI: 10.1016/s2055-6640(20)30083-2